Peritoneal equilibration testing: Your questions answered
- PMID: 36350033
- DOI: 10.1177/08968608221133629
Peritoneal equilibration testing: Your questions answered
Abstract
The peritoneal equilibration test (PET), first described in 1987, is a semiquantitative assessment of peritoneal transfer characteristics in patients undergoing peritoneal dialysis. It is typically performed as a 4-h exchange using 2.27/2.5% dextrose dialysate with serial measurements of blood and dialysate creatinine, urea, and glucose concentrations. The percentage absorption of glucose and D/P creatinine ratio are used to determine peritoneal solute transfer rates. It is used to both help guide peritoneal dialysis prescriptions and to prognosticate. There are several derivative tests which have been described in the literature. In this review, we describe the original PET, the various iterations of the PET, the information gleaned, and the use in the setting of poor solute clearance and in the diagnosis of membrane dysfunction, and limitations of the PET.
Keywords: Peritoneal equilibration testing; peritoneal solute transfer rate.
Similar articles
-
Peritoneal equilibration test curves and adequacy of dialysis in children on automated peritoneal dialysis.Am J Kidney Dis. 1994 Nov;24(5):813-8. doi: 10.1016/s0272-6386(12)80676-7. Am J Kidney Dis. 1994. PMID: 7977324
-
Prescription and assessment of tidal peritoneal dialysis delivery with a specific equilibration test.Perit Dial Int. 1996 May-Jun;16(3):295-301. Perit Dial Int. 1996. PMID: 8761544
-
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.J Nephrol. 2005 Jan-Feb;18(1):67-71. J Nephrol. 2005. PMID: 15772925 Clinical Trial.
-
[How to use the peritoneum as a dialysis membrane. Methods of surveillance, criteria of efficacy and longevity as a dialysis membrane, consequences with respect to techniques of peritoneal dialysis].Nephrologie. 1995;16(1):19-31. Nephrologie. 1995. PMID: 7700417 Review. French.
-
Biomarkers Related to Peritoneal Transfer Function and Dialysis Adequacy.Ther Apher Dial. 2025 Jun 12. doi: 10.1111/1744-9987.70052. Online ahead of print. Ther Apher Dial. 2025. PMID: 40506082 Review.
Cited by
-
Effect of Time Interval and Frequency of Hospitalization Because of Fluid Overload on Survival in Peritoneal Dialysis: Thailand Experience.Kidney360. 2024 Nov 1;5(11):1675-1682. doi: 10.34067/KID.0000000576. Epub 2024 Sep 11. Kidney360. 2024. PMID: 39259614 Free PMC article.
-
PET Testing Has Utility in the Prescription of Peritoneal Dialysis: PRO.Kidney360. 2024 Dec 1;5(12):1791-1793. doi: 10.34067/KID.0000000000000434. Epub 2024 Apr 4. Kidney360. 2024. PMID: 38573808 Free PMC article. No abstract available.
-
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality.Vaccines (Basel). 2025 Jul 2;13(7):723. doi: 10.3390/vaccines13070723. Vaccines (Basel). 2025. PMID: 40733700 Free PMC article. Review.
-
Hydrothorax with Atypical Features as a Complication of Peritoneal Dialysis: A Case Report and Literature Review.Brown J Hosp Med. 2023 Jan 1;2(1):57690. doi: 10.56305/001c.57690. eCollection 2023. Brown J Hosp Med. 2023. PMID: 40046538 Free PMC article.
-
Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States.Clin J Am Soc Nephrol. 2024 Jun 1;19(6):723-731. doi: 10.2215/CJN.0000000000000436. Epub 2024 Feb 19. Clin J Am Soc Nephrol. 2024. PMID: 38373051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical